Clinical Trials Directory

Trials / Unknown

UnknownNCT04215835

Letrozole Pretreatment With Misoprostol Induction of Abortion In First-Trimester Missed Miscarriage

Letrozole Pretreatment With Misoprostol for Induction of Abortion In First-Trimester Missed Miscarriage Among Women With One or More Previous Cesarean Deliveries.: A Randomized Controlled Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study compares the success rate of letrozole and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy among women with one or more previous cesarean deliveries.

Conditions

Interventions

TypeNameDescription
DRUGletrozole then misoprostolDrug: Letrozole 2.5mg total dose 7.5 mg per day for 3 days Drug: Misoprostol Misoprosrol 800mcg will be given to all patients for induction of abortion
DRUGplacebo then misoprostolDrug: Placebo placebo for 3 days Drug: Misoprostol Misoprosrol 800mcg will be given to all patients for induction of abortion

Timeline

Start date
2020-01-05
Primary completion
2020-04-05
Completion
2020-04-10
First posted
2020-01-02
Last updated
2020-01-02

Source: ClinicalTrials.gov record NCT04215835. Inclusion in this directory is not an endorsement.

Letrozole Pretreatment With Misoprostol Induction of Abortion In First-Trimester Missed Miscarriage (NCT04215835) · Clinical Trials Directory